Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NILOTINIB Cause Chronic obstructive pulmonary disease? 66 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Chronic obstructive pulmonary disease have been filed in association with NILOTINIB (nilotinib). This represents 0.3% of all adverse event reports for NILOTINIB.

66
Reports of Chronic obstructive pulmonary disease with NILOTINIB
0.3%
of all NILOTINIB reports
16
Deaths
24
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From NILOTINIB?

Of the 66 reports, 16 (24.2%) resulted in death, 24 (36.4%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 66 reports have been filed with the FAERS database.

What Other Side Effects Does NILOTINIB Cause?

Death (2,667) Fatigue (1,679) Rash (1,250) Nausea (1,180) Headache (1,177) Pain (1,169) Dyspnoea (1,070) Diarrhoea (998) Drug ineffective (992) Malaise (961)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which NILOTINIB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

NILOTINIB vs NIMESULIDE NILOTINIB vs NIMODIPINE NILOTINIB vs NINTEDANIB NILOTINIB vs NINTEDANIB ESYLATE NILOTINIB vs NIRAPARIB

Related Pages

NILOTINIB Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease NILOTINIB Demographics